Midatech forms scientific advisory board
This article was originally published in Scrip
Executive Summary
Abingdon, UK-based Midatech, which develops nanomedicines based on its gold-nanoparticle technology, has formed as scientific advisory board. The advisory board includes senior figures from research and industry with expertise in key areas including nanoparticles, materials chemistry, drug development and delivery, and patent protection; and will be chaired by Francesco Stellaci, Constellium professor and head of the supramolecular nanomaterials and interfaces laboratory at the École Polytechnique Fédérale de Lausanne.